Healthconn Corp. (TPEX:6665)
16.45
-0.65 (-3.80%)
Oct 8, 2026, 1:17 PM CST
Healthconn Revenue
Healthconn had revenue of 590.50M TWD in the half year ending June 30, 2026, a decrease of -1.11%. This brings the company's revenue in the last twelve months to 1.17B, down -2.54% year-over-year. In the year 2025, Healthconn had annual revenue of 1.13B, down -9.76%. That makes Healthconn the 30,048th largest company in the world by revenue and 1,489th in Taiwan.
Revenue (ttm)
1.17B
Revenue Growth
-2.54%
P/S Ratio
0.64
Revenue / Employee
5.72M
Employees
205
Market Cap
746.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13B | -122.32M | -9.76% |
| Dec 31, 2024 | 1.25B | -2.51M | -0.20% |
| Dec 31, 2023 | 1.26B | -289.50M | -18.73% |
| Dec 31, 2022 | 1.55B | 182.35M | 13.38% |
| Dec 31, 2021 | 1.36B | -144.18M | -9.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| Sofiva Genomics | 379.21M |
| BioLASCO Taiwan | 258.04M |
| Mediera | 195.89M |
| Lukas Biomedical | 170.01M |
| PlexBio | 137.57M |
| Neith | 31.84M |
| Caliway Biopharmaceuticals | 29.39M |